Prednidale is indicated as a treatment for inflammatory and allergic diseases in dogs.
Prednidale contains the active ingredient Prednisolone 25mg, a synthetic glucocorticoid (corticosteroid). Corticosteroids act on the immune system by blocking the production of substances that trigger inflammatory and immune responses.
Prednidale is administered orally, usually in the morning daily. 0.1-2.0 mg per kg body weight per day. Single administration may be sufficient for some conditions but it is usually higher for general treatment.
Prednidale (Prednisolone) 25mg tablet is indicated as a treatment for allergic and inflammatory diseases in dogs. Each Prednidale tablet contains the active ingredient Prednisolone 25mg....[More info]
Each Prednidale tablet contains the active ingredient Prednisolone 5mg. The tablets are white, circular, flat faced with a breakline and PL5 imprinted on one face and CP or DP on the...[More info]
Do not use in animals with renal insufficiency, diabetes mellitus or corneal ulceration. Do not use in animals receiving vaccines containing live organisms. Do not use in pregnant animals.
Special precautions for use:
i. Special precautions for use in animals: Pharmacologically-active dose levels may lead to atrophy of the adrenal cortex, resulting in adrenal insufficiency. This may become apparent particularly after withdrawal of corticosteroid treatment. Adrenal insufficiency may be minimised by institution of alternate-day therapy if practical. The dosage should be reduced and withdrawn gradually to avoid precipitation of adrenal insufficiency.
ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals: Gloves should be worn to administer the product and you should wash hands immediately after administration of the product. In the event of accidental ingestion, particularly by a child, seek medical advice and show the doctor the label or package leaflet.
iii. Other precautions: No special precautions required.
Adverse reactions (frequency and seriousness):
Administration of single high doses are generally tolerated well, but medium to long-term use may provoke reactions.
Corticosteroid therapy may lead to increased time in the healing of wounds and to a reduction in the ability of the body to resist infection. Appropriate anti-infective therapy may be required.
Use during pregnancy, lactation or lay:
Corticosteroids are not recommended for use in pregnant animals. Studies in laboratory animals have shown that administration during early pregnancy may cause foetal abnormalities. Administration during the later stages of pregnancy may cause abortion or early parturition.
Insignificant amounts of prednisolone are generally eliminated in the milk of lactating animals, and therefore such use is not contraindicated.